Henan Taloph Pharmaceutical Stock Co Ltd (600222) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Based on the latest financial reports, Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.69 Million ≈ $3.32 Million USD) by net assets (CN¥1.65 Billion ≈ $241.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600222 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Henan Taloph Pharmaceutical Stock Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Henan Taloph Pharmaceutical Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Henan Taloph Pharmaceutical Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Henan Taloph Pharmaceutical Stock Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Chang Jiang Shipping Group Phoenix Co Ltd SHE:000520	-0.009x
Zhejiang Noblelift Equip SHG:603611	0.154x
M31 Technology Corp TWO:6643	-0.017x
Shanghai Kinetic Medical Co SHE:300326	0.025x
Guizhou Chitianhua Co Ltd SHG:600227	0.050x
SEC Electric Mach Co Ltd SHG:603988	0.015x
Talkspace Inc NASDAQ:TALK	0.044x
PNE AG XETRA:PNE3	-0.170x

Annual Cash Flow Conversion Efficiency for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Henan Taloph Pharmaceutical Stock Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.66 Billion ≈ $243.28 Million	CN¥47.16 Million ≈ $6.90 Million	0.028x	+216.53%
2024-12-31	CN¥1.63 Billion ≈ $237.97 Million	CN¥-39.59 Million ≈ $-5.79 Million	-0.024x	-190.35%
2023-12-31	CN¥1.62 Billion ≈ $237.55 Million	CN¥43.74 Million ≈ $6.40 Million	0.027x	+134.96%
2022-12-31	CN¥1.61 Billion ≈ $236.19 Million	CN¥-124.41 Million ≈ $-18.20 Million	-0.077x	-237.49%
2021-12-31	CN¥1.78 Billion ≈ $260.12 Million	CN¥99.66 Million ≈ $14.58 Million	0.056x	+16.86%
2020-12-31	CN¥1.53 Billion ≈ $223.97 Million	CN¥73.43 Million ≈ $10.74 Million	0.048x	+51.55%
2019-12-31	CN¥1.31 Billion ≈ $191.96 Million	CN¥41.53 Million ≈ $6.08 Million	0.032x	-63.14%
2018-12-31	CN¥1.39 Billion ≈ $203.58 Million	CN¥119.47 Million ≈ $17.48 Million	0.086x	+459.02%
2017-12-31	CN¥1.51 Billion ≈ $220.70 Million	CN¥23.17 Million ≈ $3.39 Million	0.015x	-67.36%
2016-12-31	CN¥1.50 Billion ≈ $219.49 Million	CN¥70.60 Million ≈ $10.33 Million	0.047x	+43.24%
2015-12-31	CN¥1.50 Billion ≈ $219.41 Million	CN¥49.27 Million ≈ $7.21 Million	0.033x	-56.47%
2014-12-31	CN¥1.19 Billion ≈ $173.57 Million	CN¥89.54 Million ≈ $13.10 Million	0.075x	+1340.44%
2013-12-31	CN¥1.09 Billion ≈ $159.85 Million	CN¥-6.65 Million ≈ $-972.81K	-0.006x	-104.57%
2012-12-31	CN¥656.50 Million ≈ $96.07 Million	CN¥87.45 Million ≈ $12.80 Million	0.133x	+79526.32%
2011-12-31	CN¥628.89 Million ≈ $92.03 Million	CN¥105.20K ≈ $15.39K	0.000x	+100.51%
2010-12-31	CN¥609.32 Million ≈ $89.16 Million	CN¥-20.00 Million ≈ $-2.93 Million	-0.033x	-189.72%
2009-12-31	CN¥586.04 Million ≈ $85.76 Million	CN¥21.45 Million ≈ $3.14 Million	0.037x	+12.00%
2008-12-31	CN¥554.97 Million ≈ $81.21 Million	CN¥18.13 Million ≈ $2.65 Million	0.033x	-20.12%
2007-12-31	CN¥521.57 Million ≈ $76.32 Million	CN¥21.34 Million ≈ $3.12 Million	0.041x	+1149.87%
2006-12-31	CN¥487.05 Million ≈ $71.27 Million	CN¥1.59 Million ≈ $233.25K	0.003x	+459.04%
2005-12-31	CN¥471.96 Million ≈ $69.06 Million	CN¥276.30K ≈ $40.43K	0.001x	-98.54%
2004-12-31	CN¥455.68 Million ≈ $66.68 Million	CN¥18.25 Million ≈ $2.67 Million	0.040x	+371.94%
2003-12-31	CN¥440.61 Million ≈ $64.48 Million	CN¥3.74 Million ≈ $547.22K	0.008x	-51.32%
2002-12-31	CN¥428.30 Million ≈ $62.67 Million	CN¥7.47 Million ≈ $1.09 Million	0.017x	-86.79%
2001-12-31	CN¥416.84 Million ≈ $61.00 Million	CN¥55.03 Million ≈ $8.05 Million	0.132x	+6089.51%
2000-12-31	CN¥410.41 Million ≈ $60.06 Million	CN¥875.36K ≈ $128.09K	0.002x	-99.14%
1999-12-31	CN¥401.57 Million ≈ $58.76 Million	CN¥99.32 Million ≈ $14.53 Million	0.247x	+36.58%
1998-12-31	CN¥154.84 Million ≈ $22.66 Million	CN¥28.04 Million ≈ $4.10 Million	0.181x	--

About Henan Taloph Pharmaceutical Stock Co Ltd

SHG:600222 China Drug Manufacturers - Specialty & Generic

Market Cap

$649.99 Million

CN¥4.44 Billion CNY

Market Cap Rank

#11090 Global

#3140 in China

Share Price

CN¥7.74

Change (1 day)

-1.78%

52-Week Range

CN¥5.57 - CN¥8.70

All Time High

CN¥10.35